Is it prudent to add n-3 long-chain polyunsaturated fatty acids to paediatric enteral tube feeding?

Clinical Nutrition

Volumn 30, Issue 3, 2011, Pages 273-281

  Sijben, John W C ^a   Goedhart, Annemiek C ^a   Kamphuis, Patrick J G H ^a,b   Calder, Philip C ^c   Gottrand, Frédéric ^d   Koletzko, Berthold ^e  

^a DANONE RESEARCH   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITÉ DE LILLE   (France)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Children; Docosahexaenoic acid (DHA); Eicosapentaenoic acid (EPA); Enteral nutrition; Long chain polyunsaturated fatty acids (LC PUFA); Omega 3

Indexed keywords

DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID;

BIOSYNTHESIS; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; ENTERIC FEEDING; FATTY ACID BLOOD LEVEL; HUMAN; IMMUNE SYSTEM; NERVOUS SYSTEM; NUTRIENT; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; REVIEW; TISSUE LEVEL;

ADOLESCENT; ADOLESCENT DEVELOPMENT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; HUMANS; INFANT; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; PRACTICE GUIDELINES AS TOPIC;

EID: 79957566150     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2010.11.007     Document Type: Review

References (123)

1. Joosten K.F., Hulst J.M. Prevalence of malnutrition in pediatric hospital patients. Curr Opin Pediatr 2008, 20:590-596.
2. Pawellek I., Dokoupil K., Koletzko B. Prevalence of malnutrition in paediatric hospital patients. Clin Nutr 2008, 27:72-76.
3. Shaw V., Lawson M. Clinical paediatric dietetics 2007, Blackwell Publishing. 3rd ed.
4. Braegger C., Decsi T., Dias J., Hartman C., Kolacek S., Koletzko B., et al. Practical approach to paediatric enteral nutrition: a comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010, 51:110-122.
5. Nevin-Folino N.L. Pediatric manual of clinical dietetics 2003, Developed by The American Dietetic Association's Pediatric Nutrition Practice Group, The American Dietetic Association. 2nd ed.
6. Marchand V., Baker S.S., Baker R.D. Enteral nutrition in the pediatric population. Gastrointest Endosc Clin N Am 1998, 8:669-703.
7. Koletzko B., Lien E., Agostoni C., Bohles H., Campoy C., Cetin I., et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 2008, 36:5-14.
8. Plourde M., Cunnane S.C. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 2007, 32:619-634.
9. Schuchardt J.P., Huss M., Stauss-Grabo M., Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr 2010, 169:149-164.
10. Koletzko B., Uauy R., Palou A., Kok F., Hornstra G., Eilander A., et al. Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children - a workshop report. Br J Nutr 2010, 103:923-928.
11. Gottrand F., Sullivan P.B. Gastrostomy tube feeding: when to start, what to feed and how to stop. Eur J Clin Nutr 2010, 1(64 Suppl):S17-S21.
12. Annual BANS Report Artificial nutrition support in the UK 2000-2008 2009, at, Committee of The British Association for Parenteral and Enteral Nutrition (BAPEN), accessed March 2010. http://www.bapen.org.uk/pdfs/bans_reports/bans_report_09.pdf.
13. Daveluy W., Guimber D., Uhlen S., Lescut D., Michaud L., Turck D., et al. Dramatic changes in home-based enteral nutrition practices in children during an 11-year period. J Pediatr Gastroenterol Nutr 2006, 43:240-244.
14. Diamanti A., Pietrobattista A., Gambarara M. Home enteral nutrition in children: a 17-year period experience. Clin Nutr 2006, 25:173-174.
15. Daveluy W., Guimber D., Mention K., Lescut D., Michaud L., Turck D., et al. Home enteral nutrition in children: an 11-year experience with 416 patients. Clin Nutr 2005, 24:48-54.
16. Calder P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008, 52:885-897.
17. Cetin I., Koletzko B. Long-chain omega-3 fatty acid supply in pregnancy and lactation. Curr Opin Clin Nutr Metab Care 2008, 11:297-302.
18. Wurtman R.J., Cansev M., Sakamoto T., Ulus I.H. Use of phosphatide precursors to promote synaptogenesis. Annu Rev Nutr 2009, 29:59-87.
19. Salem N., Wegher B., Mena P., Uauy R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci U S A 1996, 93:49-54.
20. Sauerwald T.U., Hachey D.L., Jensen C.L., Chen H., Anderson R.E., Heird W.C. Intermediates in endogenous synthesis of C22:6 omega 3 and C20:4 omega 6 by term and preterm infants. Pediatr Res 1997, 41:183-187.
21. Makrides M., Neumann M.A., Byard R.W., Simmer K., Gibson R.A. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994, 60:189-194.
22. Makrides M., Neumann M., Simmer K., Pater J., Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy?. Lancet 1995, 345:1463-1468.
23. Agostoni C., Riva E., Trojan S., Bellu R., Giovannini M. Docosahexaenoic acid status and developmental quotient of healthy term infants. Lancet 1995, 346:638.
24. Birch E.E., Hoffman D.R., Uauy R., Birch D.G., Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res 1998, 44:201-209.
25. Clandinin M.T., Chappell J.E., van Aerde J.E. Requirements of newborn infants for long chain polyunsaturated fatty acids. Acta Paediatr Scand Suppl 1989, 351:63-71.
26. Farquharson J., Cockburn F., Patrick W.A., Jamieson E.C., Logan R.W. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 1992, 340:810-813.
27. Farquharson J., Jamieson E.C., Abbasi K.A., Patrick W.J., Logan R.W., Cockburn F. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch Dis Child 1995, 72:198-203.
28. Greiner R.C., Winter J., Nathanielsz P.W., Brenna J.T. Brain docosahexaenoate accretion in fetal baboons: bioequivalence of dietary alpha-linolenic and docosahexaenoic acids. Pediatr Res 1997, 42:826-834.
29. Burdge G.C., Calder P.C. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005, 45:581-597.
30. Burdge G.C. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot Essent Fatty Acids 2006, 75:161-168.
31. Lattka E., Illig T., Heinrich J., Koletzko B. FADS gene cluster polymorphisms: important modulators of fatty acid levels and their impact on atopic diseases. J Nutrigenet Nutrigenomics 2009, 2:119-128.
32. Schaeffer L., Gohlke H., Muller M., Heid I.M., Palmer L.J., Kompauer I., et al. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006, 15:1745-1756.
33. Lattka E., Illig T., Koletzko B., Heinrich J. Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol 2010, 21:64-69.
34. Beblo S., Reinhardt H., Muntau A.C., Mueller-Felber W., Roscher A.A., Koletzko B. Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology 2001, 57:1488-1491.
35. Fokkema M.R., Brouwer D.A., Hasperhoven M.B., Hettema Y., Bemelmans W.J., Muskiet F.A. Polyunsaturated fatty acid status of Dutch vegans and omnivores. Prostaglandins Leukot Essent Fatty Acids 2000, 63:279-285.
36. Lee H.Y., Woo J., Chen Z.Y., Leung S.F., Peng X.H. Serum fatty acid, lipid profile and dietary intake of Hong Kong Chinese omnivores and vegetarians. Eur J Clin Nutr 2000, 54:768-773.
37. Rosell M.S., Lloyd-Wright Z., Appleby P.N., Sanders T.A., Allen N.E., Key T.J. Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. Am J Clin Nutr 2005, 82:327-334.
38. Galli C., Agostoni C., Mosconi C., Riva E., Salari P.C., Giovannini M. Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J Pediatr 1991, 119:562-567.
39. Poge A.P., Baumann K., Muller E., Leichsenring M., Schmidt H., Bremer H.J. Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake. J Inherit Metab Dis 1998, 21:373-381.
40. Gomez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 2008, 9:568-578.
41. Carver J.D., Benford V.J., Han B., Cantor A.B. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res Bull 2001, 56:79-85.
42. Mirnikjoo B., Brown S.E., Kim H.F., Marangell L.B., Sweatt J.D., Weeber E.J. Protein kinase inhibition by omega-3 fatty acids. J Biol Chem 2001, 276:10888-10896.
43. Seung Kim H.F., Weeber E.J., Sweatt J.D., Stoll A.L., Marangell L.B. Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro. Mol Psychiatry 2001, 6:246-248.
44. Berger A., Mutch D.M., German J.B., Roberts M.A. Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis 2002, 1:2.
45. Kitajka K., Sinclair A.J., Weisinger R.S., Weisinger H.S., Mathai M., Jayasooriya A.P., et al. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci U S A 2004, 101:10931-10936.
46. Kim H.Y., Akbar M., Kim Y.S. Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2010.
47. Zimmer L., Vancassel S., Cantagrel S., Breton P., Delamanche S., Guilloteau D., et al. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 2002, 75:662-667.
48. McNamara R.K., Able J., Jandacek R., Rider T., Tso P., Eliassen J.C., et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr 2010.
49. Ryan A.S., Nelson E.B. Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study. Clin Pediatr (Phila) 2008, 47:355-362.
50. Dalton A., Wolmarans P., Witthuhn R.C., van Stuijvenberg M.E., Swanevelder S.A., Smuts C.M. A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot Essent Fatty Acids 2009, 80:143-149.
51. Muthayya S., Eilander A., Transler C., Thomas T., van der Knaap H.C., Srinivasan K., et al. Effect of fortification with multiple micronutrients and n-3 fatty acids on growth and cognitive performance in Indian schoolchildren: the CHAMPION (Children's Health and Mental Performance Influenced by Optimal Nutrition). Study Am J Clin Nutr 2009, 89:1766-1775.
52. Kennedy D.O., Jackson P.A., Elliott J.M., Scholey A.B., Robertson B.C., Greer J., et al. Cognitive and mood effects of 8 weeks' supplementation with 400 mg or 1000 mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10-12 years. Nutr Neurosci 2009, 12:48-56.
53. Osendarp S.J., Baghurst K.I., Bryan J., Calvaresi E., Hughes D., Hussaini M., et al. Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia. Am J Clin Nutr 2007, 86:1082-1093.
54. Kirby A., Woodward A., Jackson S., Wang Y., Crawford M.A. A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population. Res Dev Disabil 2010, 31:718-730.
55. Antalis C.J., Stevens L.J., Campbell M., Pazdro R., Ericson K., Burgess J.R. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2006, 75:299-308.
56. Chen J.R., Hsu S.F., Hsu C.D., Hwang L.H., Yang S.C. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J Nutr Biochem 2004, 15:467-472.
57. Colter A.L., Cutler C., Meckling K.A. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr J 2008, 7:8.
58. Stevens L.J., Zentall S.S., Deck J.L., Abate M.L., Watkins B.A., Lipp S.R., et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995, 62:761-768.
59. Morse N.L. A meta-analysis of blood fatty acids in people with learning disorders with particular interest in arachidonic acid. Prostaglandins Leukot Essent Fatty Acids 2009, 81:373-389.
60. Brookes K.J., Chen W., Xu X., Taylor E., Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006, 60:1053-1061.
61. Ng K.H., Meyer B.J., Reece L., Sinn N. Dietary PUFA intakes in children with attention-deficit/hyperactivity disorder symptoms. Br J Nutr 2009, 102:1635-1641.
62. Richardson A.J., Puri B.K. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:233-239.
63. Richardson A.J., Montgomery P. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 2005, 115:1360-1366.
64. Amminger G.P., Berger G.E., Schafer M.R., Klier C., Friedrich M.H., Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 2007, 61:551-553.
65. Sorgi P.J., Hallowell E.M., Hutchins H.L., Sears B. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J 2007, 6:16.
66. Stordy B. J. Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia. Am J Clin Nutr 2000, 71:323S-326S.
67. Sinn N., Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J Dev Behav Pediatr 2007, 28:82-91.
68. Johnson M., Ostlund S., Fransson G., Kadesjo B., Gillberg C. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J Atten Disord 2009, 12:394-401.
69. Voigt R.G., Llorente A.M., Jensen C.L., Fraley J.K., Berretta M.C., Heird W.C. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr 2001, 139:189-196.
70. Hirayama S., Hamazaki T., Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study. Eur J Clin Nutr 2004, 58:467-473.
71. Stevens L., Zhang W., Peck L., Kuczek T., Grevstad N., Mahon A., et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids 2003, 38:1007-1021.
72. Koletzko B., Beblo S., Demmelmair H., Hanebutt F.L. Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU). J Pediatr Gastroenterol Nutr 2009, 1(48 Suppl):S2-S7.
73. Beblo S., Reinhardt H., Demmelmair H., Muntau A.C., Koletzko B. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr 2007, 150:479-484.
74. Kew S., Banerjee T., Minihane A.M., Finnegan Y.E., Muggli R., Albers R., et al. Lack of effect of foods enriched with plant- or marine-derived n-3 fatty acids on human immune function. Am J Clin Nutr 2003, 77:1287-1295.
75. Kew S., Mesa M.D., Tricon S., Buckley R., Minihane A.M., Yaqoob P. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 2004, 79:674-681.
76. Sijben J.W., Boehm G., Calder P.C. Fatty Acids in immunomodulation: role in disease prevention and causation. Fatty acids in health promotion and disease causation 2009, 545-584. AOCS Press, Urbana, Illinois. R.R. Watson (Ed.).
77. Healy D.A., Wallace F.A., Miles E.A., Calder P.C., Newsholm P. Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 2000, 35:763-768.
78. Rees D., Miles E.A., Banerjee T., Wells S.J., Roynette C.E., Wahle K.W., et al. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr 2006, 83:331-342.
79. Calder P.C. The 2008 ESPEN Sir David Cuthbertson lecture: fatty acids and inflammation-from the membrane to the nucleus and from the laboratory bench to the clinic. Clin Nutr 2010, 29:5-12.
80. Semba R.D. Vitamin A as "anti-infective" therapy, 1920-1940. J Nutr 1999, 129:783-791.
81. Linday L.A., Shindledecker R.D., Tapia-Mendoza J., Dolitsky J.N. Effect of daily cod liver oil and a multivitamin-mineral supplement with selenium on upper respiratory tract pediatric visits by young, inner-city, Latino children: randomized pediatric sites. Ann Otol Rhinol Laryngol 2004, 113:891-901.
82. Linday L.A., Dolitsky J.N., Shindledecker R.D., Pippenger C.E. Lemon-flavored cod liver oil and a multivitamin-mineral supplement for the secondary prevention of otitis media in young children: pilot research. Ann Otol Rhinol Laryngol 2002, 111:642-652.
83. Damsgaard C.T., Lauritzen L., Kjaer T.M., Holm P.M., Fruekilde M.B., Michaelsen K.F., et al. Fish oil supplementation modulates immune function in healthy infants. J Nutr 2007, 137:1031-1036.
84. Minns L.M., Kerling E.H., Neely M.R., Sullivan D.K., Wampler J.L., Harris C.L., et al. Toddler formula supplemented with docosahexaenoic acid (DHA) improves DHA status and respiratory health in a randomized, double-blind, controlled trial of US children less than 3 years of age. Prostaglandins Leukot Essent Fatty Acids 2010, 82:287-293.
85. Vaisman N., Zaruk Y., Shirazi I., Kaysar N., Barak V. The effect of fish oil supplementation on cytokine production in children. Eur Cytokine Netw 2005, 16:194-198.
86. Thienprasert A., Samuhaseneetoo S., Popplestone K., West A.L., Miles E.A., Calder P.C. Fish oil n-3 polyunsaturated fatty acids selectively affect plasma cytokines and decrease illness in Thai schoolchildren: a randomized, double-blind, placebo-controlled intervention trial. J Pediatr 2009, 154:391-395.
87. Chatzi L., Torrent M., Romieu I., Garcia-Esteban R., Ferrer C., Vioque J., et al. Diet, wheeze, and atopy in school children in Menorca, Spain. Pediatr Allergy Immunol 2007, 18:480-485.
88. Hodge L., Salome C.M., Peat J.K., Haby M.M., Xuan W., Woolcock A.J. Consumption of oily fish and childhood asthma risk. Med J Aust 1996, 164:137-140.
89. Nafstad P., Nystad W., Magnus P., Jaakkola J.J. Asthma and allergic rhinitis at 4 years of age in relation to fish consumption in infancy. J Asthma 2003, 40:343-348.
90. Dunder T., Kuikka L., Turtinen J., Rasanen L., Uhari M. Diet, serum fatty acids, and atopic diseases in childhood. Allergy 2001, 56:425-428.
91. Farchi S., Forastiere F., Agabiti N., Corbo G., Pistelli R., Fortes C., et al. Dietary factors associated with wheezing and allergic rhinitis in children. Eur Respir J 2003, 22:772-780.
92. Hijazi N., Abalkhail B., Seaton A. Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia. Thorax 2000, 55:775-779.
93. Takemura Y., Sakurai Y., Honjo S., Tokimatsu A., Gibo M., Hara T., et al. The relationship between fish intake and the prevalence of asthma: the Tokorozawa childhood asthma and pollinosis study. Prev Med 2002, 34:221-225.
94. Mihrshahi S., Peat J.K., Marks G.B., Mellis C.M., Tovey E.R., Webb K., et al. Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS). J Allergy Clin Immunol 2003, 111:162-168.
95. Marks G.B., Mihrshahi S., Kemp A.S., Tovey E.R., Webb K., Almqvist C., et al. Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol 2006, 118:53-61.
96. Peat J.K., Mihrshahi S., Kemp A.S., Marks G.B., Tovey E.R., Webb K., et al. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol 2004, 114:807-813.
97. Hodge L., Salome C.M., Hughes J.M., Liu-Brennan D., Rimmer J., Allman M., et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 1998, 11:361-365.
98. Nagakura T., Matsuda S., Shichijyo K., Sugimoto H., Hata K. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 2000, 16:861-865.
99. Thien F.C.K., De Luca S., Woods R.K., Abramson M.J. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev 2000, CD001283.
100. Hartman C., Eliakim R., Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol 2009, 15:2570-2578.
101. Engel M.A., Neurath M.F. New pathophysiological insights and modern treatment of IBD. J Gastroenterol 2010, 45:571-583.
102. Amre D.K., D'Souza S., Morgan K., Seidman G., Lambrette P., Grimard G., et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007, 102:2016-2025.
103. Romano C., Cucchiara S., Barabino A., Annese V., Sferlazzas C. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol 2005, 11:7118-7121.
104. Turner D., Zlotkin S.H., Shah P.S., Griffiths A.M. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009, CD006320.
105. Turner D., Steinhart A.H., Griffiths A.M. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007, CD006443.
106. Doring G., Bellon G., Knight R. Immunology and cystic fibrosis. Cystic fibrosis 2000, 109-140. Hodder Arnold,, London. M. Hodson, D. Geddes (Eds.).
107. Erskine J.M., Lingard C., Sontag M. Update on enteral nutrition support for cystic fibrosis. Nutr Clin Pract 2007, 22:223-232.
108. Peterson M.L., Jacobs D.R., Milla C.E. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics 2003, 112:588-592.
109. Michel S.H., Maqbool A., Hanna M.D., Mascarenhas M. Nutrition management of pediatric patients who have cystic fibrosis. Pediatr Clin North Am 2009, 56:1123-1141.
110. Davies J.C. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respir Rev 2002, 3:128-134.
111. Pierre M., Husson M.O., Le Berre R., Desseyn J.L., Galabert C., Beghin L., et al. Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1422-L1431.
112. De Vizia B., Raia V., Spano C., Pavlidis C., Coruzzo A., Alessio M. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. J Parenter Enteral Nutr 2003, 27:52-57.
113. Kurlandsky L.E., Bennink M.R., Webb P.M., Ulrich P.J., Baer L.J. The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis. Pediatr Pulmonol 1994, 18:211-217.
114. Van Biervliet S., Devos M., Delhaye T., Van Biervliet J.P., Robberecht E., Christophe A. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients. Prostaglandins Leukot Essent Fatty Acids 2008, 78:109-115.
115. Tuxen-Mengedoht M., Koletzko B., Muller I. Fish oil therapy in cystic fibrosis (CF): a randomized clinical trial [abstract]. Clin Nutr 1999, 18:54.
116. Lawrence R., Sorrell T. Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4. Lancet 1993, 342:465-469.
117. Dietary reference Intakes: energy, proteins, fats and digestible carbohydrates 2001, Health Council of the Netherlands, Health Council of the Netherlands, The Hague, publication no. 2001/2019, ISBN 2090-5549-2384-2008.
118. Recommandations nutrionnelles pour la Belgique 2009, Superior Health Council of Belgium, at Revision 2009 CSS 8309, accessed March 2010. http://v2p.health.belgium.be/filestore/18014679_FR/CSS_8309_FR_18014679_fr.pdf.
119. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 2007, 107:1599-1611. American Dietetic Association and Dieticians of Canada.
120. Advice on fish consumption: benefits & risks 2004, Scientific Advisory Committee on Nutrition, London.
121. Scientific opinion dietary reference: values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J 2010, 8:1461. EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA).
122. Guidelines for a healthy diet 2006, Health Council of the Netherlands, Health Council of the Netherlands, The Hague, publication no. 2006/21E.
123. Koletzko B., Beblo S., Demmelmair H., Muller-Felber W., Hanebutt F.L. Does dietary DHA improve neural function in children? Observations in phenylketonuria. Prostaglandins Leukot Essent Fatty Acids 2009, 81:159-164.